Treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination
Interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
392 Antidotes
3929 Others
D05419 Pentetate calcium trisodium (JAN/USAN); Calcium trisodium pentetate (INN)
Drug groups [BR:br08330]
Vitamin and mineral
DG01692 Chelator
D05419 Pentetate calcium trisodium
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05419
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05419
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05419